[Ip-health] Novartis, Dana Farber, Oregon Health & Science University Wait 18 Years to Disclose NIHFunding in Key Gleevec Patent | Bill of Health

Joseph Fortunak jfortunak at comcast.net
Fri Oct 11 09:58:28 PDT 2019


CONGRATULATIONS JAMIE, well done indeed!!

Sent from Mail for Windows 10

From: James Love
Sent: Friday, October 11, 2019 12:09 PM
To: Ip-health
Subject: [Ip-health] Novartis, Dana Farber,Oregon Health & Science University Wait 18 Years to Disclose NIHFunding in Key Gleevec Patent | Bill of Health

After 18 years, Novartis gets around to disclosing NIH funding in a Gleevec
patent.

Jamie


http://blog.petrieflom.law.harvard.edu/2019/10/11/novartis-dana-farber-oregon-health-science-university-wait-18-years-to-disclose-nih-funding-in-key-gleevec-patent/

This is a story about U.S. patent number 6,958,335, and how it took more
than 18 years for Novartis to acknowledge National Institutes of Health
(NIH) funding in a key patent for Gleevec, allowing Novartis to shape the
narrative regarding its role in the development of Gleevec, and also to
avoid demands that Novartis make the invention “available to the public on
reasonable terms,” which is an obligation under the Bayh-Dole Act.
....
_______________________________________________
Ip-health mailing list
Ip-health at lists.keionline.org
http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org



-- 
This email has been checked for viruses by Avast antivirus software.
https://www.avast.com/antivirus


More information about the Ip-health mailing list